Related Experiment Videos
Medication nonadherence: Part II--A pilot study in patients with congestive heart failure
1Virginia Commonwealth University School of Pharmacy, Richmond, USA.
Managed Care Interface
|August 5, 1998
Summary
Patient medication nonadherence is a major US health issue. This study identified key factors contributing to nonadherence in congestive heart failure patients using angiotensin-converting enzyme inhibitors.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Medication nonadherence significantly increases morbidity, mortality, and healthcare costs in the United States.
- Understanding the factors influencing nonadherence is crucial for improving patient outcomes in chronic conditions.
Purpose of the Study:
- To identify the principal factors contributing to nonadherence to pharmaceutical therapy.
- To evaluate these factors in patients with congestive heart failure (CHF).
Main Methods:
- A pilot study was conducted involving 311 patients diagnosed with CHF.
- Participants were prescribed an angiotensin-converting enzyme (ACE) inhibitor medication.
- The study assessed various factors related to patient adherence.
Main Results:
- The study identified several key factors influencing nonadherence in this patient population.
- Specific details on the principal factors are elaborated in the full article.
Conclusions:
- Nonadherence to ACE inhibitor therapy in CHF patients is influenced by identifiable factors.
- Addressing these factors may improve medication adherence and subsequent patient health outcomes.